This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Founded in 1994, Alexandria Real Estate Equities, Inc. is a Pasadena, CA-based urban office real estate investment trust (REIT) with particular focus on collaborative life science, agtech and technology campuses. The company’s assets are located in the AAA innovation cluster locations of North America, with considerable market presence in Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle. The company enjoys a solid 10-year historical occupancy rate of 96% at operating properties in North America.
Boston Properties (BXP) Q1 FFO & Revenues Top, '23 View Up
by Zacks Equity Research
Boston Properties' (BXP) Q1 results outshine estimates on better-than-anticipated revenues, aided by healthy leasing activity. It raises its 2023 guidance for FFO per share.
Alexandria (ARE) Q1 FFO Tops on Rent Growth, '23 View Revised
by Zacks Equity Research
Alexandria Real Estate's (ARE) Q1 results outshine estimates on healthy leasing activity and solid rental rate growth. It narrows its 2023 adjusted FFO per share outlook.
Alexandria Real Estate Equities (ARE) Beats Q1 FFO and Revenue Estimates
by Zacks Equity Research
Alexandria Real Estate Equities (ARE) delivered FFO and revenue surprises of 1.86% and 3.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Crown Castle's (CCI) Q1 AFFO Lags Estimates, Revenues Up Y/Y
by Zacks Equity Research
Amid elevated tower space demand for 5G deployment, Crown Castle's (CCI) top line improves year over year on healthy site-rental revenue growth. It maintains its 2023 outlook.
SL Green's (SLG) FFO and Revenues Surpass Estimates in Q1
by Zacks Equity Research
SL Green's (SLG) Q1 earnings outshine estimates on better-than-anticipated revenues. However, the occupancy in the company's Manhattan same-store office portfolio falls year over year.
Prologis (PLD) Beats Q1 FFO Estimates on Solid Rent Growth
by Zacks Equity Research
Prologis (PLD) puts up a decent show in the first quarter on robust activity and rent growth.
What's in Store for Alexandria (ARE) This Earnings Season?
by Zacks Equity Research
Robust demand for high-quality life science and lab office properties in key markets, creditworthy tenants and adequate financial flexibility are likely to have aided Alexandria's (ARE) Q1 earnings.
Alexandria (ARE) Transfers Partial Interest in 15 Necco Street
by Zacks Equity Research
Amid the solid demand for high-quality life science assets, Alexandria (ARE) closes the strategic partial interest transaction for 15 Necco Street to a U.S. affiliate of Mori Trust Co., Ltd.
Alexandria Real Estate Equities (ARE) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.
Here's Why You Should Retain Alexandria (ARE) Stock for Now
by Zacks Equity Research
Solid demand for high-quality life science and lab office properties in key markets and strategic buyouts bode well for Alexandria (ARE). However, interest rate hikes are a key concern.
3 Top Dividend Stocks to Maximize Your Retirement Income
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Should Investors Retain OUTFRONT Media (OUT) Stock for Now?
by Zacks Equity Research
OUTFRONT Media's (OUT) diversified advertising sites and strategic investments for digital-billboard conversions bode well. However, stiff competition and rising interest rates are worrisome.
Medical Properties (MPW) to Dispose of Healthscope Portfolio
by Zacks Equity Research
Medical Properties (MPW) enters an agreement with affiliates of HMC Capital to dispose of its Healthscope portfolio. The move is in line with its capital recycling strategy.
Is it Wise to Retain Equity Residential (EQR) Stock for Now?
by Zacks Equity Research
Healthy demand for residential properties, expansionary efforts and technological innovations bode well for Equity Residential (EQR). The lack of rent relief and interest rate hikes are worrisome.
Four Corners (FCPT) on Buying Spree, Acquires Indiana Asset
by Zacks Equity Research
To strengthen its portfolio with real estate leased to strong credit operators, Four Corners (FCPT) announces the acquisition of a WellNow Urgent Care property in Indiana for $2.5 million.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Should You Retain Highwoods (HIW) Stock in Your Portfolio Now?
by Zacks Equity Research
Healthy Sun Belt office market fundamentals and expansionary efforts into the BBD markets bode well for Highwoods (HIW). However, rising office supply and interest rate hikes are key concerns.
Pebblebrook (PEB) Sells Hotel Colonnade Coral Gables for $63M
by Zacks Equity Research
Pebblebrook (PEB) carries out the disposition of The Hotel Colonnade Coral Gables, Autograph Collection in Coral Gables, FL, for $63 million. The move is in line with its investment strategy.
SL Green (SLG) Inks Lease With Palo Alto at One Madison Avenue
by Zacks Equity Research
SL Green (SLG) announces the signing of a long-term lease with Palo Alto Networks at One Madison Avenue, reflecting the decent demand for its high-quality and well-amenetized office properties.
Four Corners (FCPT) Boosts Portfolio, Buys Property for $3.3M
by Zacks Equity Research
To enhance its portfolio quality with real estate leased to strong credit operators, Four Corners (FCPT) acquires a Methodist Le Bonheur Pediatric Clinic property in Tennessee for $3.3 million.
Should Investors Hold on to AvalonBay (AVB) Stock for Now?
by Zacks Equity Research
Healthy demand for residential properties, strategic buyouts and technological innovations bode well for AvalonBay (AVB). However, the lack of rent relief and interest rate hikes are worrisome.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.
Lamar's (LAMR) Stock Gains 10.2% in 6 Months: Here's Why
by Zacks Equity Research
Healthy operating performance, strategic acquisitions and a robust balance-sheet hike Lamar's (LAMR) shares 10.2% in the past six months.
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Americold (COLD) Boosts Portfolio With New Facility in Spain
by Zacks Equity Research
Americold (COLD) announces the opening of its fourth facility expansion in Barcelona, Spain. The move enhances the company's portfolio by adding 11 loading bays and 12,000 pallet positions.